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Tumor–stromal interactions are important for the progres-
sion of malignant tumors. The purpose of the present study
was to examine interactions of cholangiocarcinoma (CC)
cells and stromal fibroblasts with respect to stromal-
derived factor-1 (SDF-1) and transforming growth factor
(TGF)-b1. Two cell lines of CC (HuCCT-1 and CCKS-1) and
WI-38 fibroblast cell line were used for cell culture, and 12
CC tissue specimens for immunohistochemical studies.
Invasion of CC cells was increased significantly by the
supernatant from fibroblast cultures, but not by the super-
natant from fibroblasts cocultured with CC cells. Expres-
sion of SDF-1 in cultured fibroblasts was downregulated by
TGF-b1 treatment, and coculture with CC cells and anti-
TGF-b1 neutralizing antibody restored the decreased SDF-
1 expression, suggesting that TGF-b1 secreted from CC
cells might have reduced the expression of SDF-1 by fibro-
blasts and might have reduced the increased invasion of
CC cells induced by the supernatant from fibroblasts.
Immunohistochemical expression of TGF-b1 in CC cells was
focal or negative and that of SDF-1 was evident in stromal
fibroblasts at the invasive front of CC. In conclusion, local
mutual influence of TGF-b1 secreted from carcinoma cells
and SDF-1 expressed by stromal fibroblasts may be
involved in invasion of CC cells.
Key words: cholangiocarcinoma, fibroblasts, invasion, SDF-1,
TGFβ-1, tumor stroma 
Recently, there has been increasing evidence that tumor
stromal cells provide a unique microenvironment that is piv-
otal for tumor cell growth, invasion and metastasis.1–6 Crucial
in this process are fibroblasts that are located in the vicinity
of neoplastic epithelial cells. These fibroblasts can produce
an extracellular matrix (ECM) that is used as an anchorage
for tumor cell, and also functions as a reservoir of growth
factors derived from tumor and stromal cells.7,8 As the spe-
cific paracrine factors in the tumor–stromal interactions, var-
ious growth factors and their receptors, including hepatocyte
growth factor (HGF)/c-Met, stromal-derived factor-1 (SDF-1)/
CXCR4 (a specific receptor of SDF-1), and epidermal growth
factor (EGF)/EGF-R, have been reported.6,9–12 Among them,
SDF-1, which is known to be expressed in the stromal fibro-
blasts and endothelial cells, strongly promotes invasion and
directional chemotaxis of tumor cells and also increases the
adhesion of tumor cells.12,13 In addition, CXCR4 is expressed
significantly in the malignant tumors and SDF-1–CXCR4
interaction is involved in tumor progression, especially in
brain and breast tumors.14 Our recent study showed that the
interaction of SDF-1 released from fibroblasts and CXCR4
expressed on cholangiocarcinoma (CC) cells is actively
involved in the invasion of CC, and that tumor necrosis factor-
α (TNF-α) expressed at the interface of CC may enhance the
invasion of CC cells by increasing CXCR4 expression on CC
cells.12
Transforming growth factor (TGF)-β, which is involved in
the signaling network for several autocrine and paracrine
mechanisms, is known as an important mediator of tumor–
stromal  interactions  and  is  responsible  for  regulation  of
cell proliferation, cell motility, and neoplastic transforma-
tion.5,12,15,16 For example, Bhowmick et al. have recently
reported  that  stromal  cells  influence  the  carcinogenesis
and progression process in adjacent epithelia by changing
TGF-β signaling in fibroblasts.5 As for the role of TGF-β in
tumor–stromal interactions in CC, overexpressed TGF-β1
and vascular endothelial growth factor (VEGF) and their
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receptors in CC cells and endothelial cells might contribute
to the ‘angiogenic switch’ and malignant transformation of
biliary epithelial cells.17 In CC with hepatolithiasis, TGF-β1
was immunohistochemically expressed in mononuclear cells
and mesenchymal cells around the stone-containing bile
ducts and invasive CC, and also in hyperplastic and dysplas-
tic biliary epithelial cells.18 TGF-β receptor (TβR-II) was con-
stantly expressed on biliary epithelial cells irrespective of
biliary lesions. A high level of TGF-β1 around CC or its
precursors may be involved in development and progression
of CC via interaction with TβR-II expressed on these lesions.18
As for the relationship between SDF-1 and TGF-β1, TGF-
β1 is known to control the proliferation and differentiation of
hematopoietic progenitor cells by downregulating SDF-1
expression in the bone marrow stem cell.19 Salvucci et al.
reported that basic fibroblast growth factor (bFGF) increases
SDF-1 expression in endothelial cells and SDF-1/CXCR-4
identifies bFGF-regulated autocrine signaling systems that
are essential regulators of angiogenesis.20 However, there
have been no studies on the interaction of SDF-1 and TGF-
β1 in CC, so far.
To clarify the tumor–stromal interactions in CC, and deter-
mine whether SDF-1 expressed in the stromal fibroblasts and
TGF-β1 expressed in carcinoma cells influence each other,
we cultured CC and fibroblast cell lines and carried out immu-
nohistochemistry for human CC tissues.
MATERIALS AND METHODS
Patients selection and tissue processing 
of CC specimens
Twelve cases of surgically resected CC located at hepatic
hilar and/or perihilar regions21,22 (10 men and two women)
were consecutively retrieved from the Biliary Disease files of
the Department of Surgery, Nagoya University Graduate
School of Medicine, Nagoya, Japan, in 2003. The mean age
of the patients was 65.5 years (range: 59–80 years). Surgical
procedures were partial hepatectomy with extrahepatic bile
duct resection in all cases. Specimens were collected as a
result of routine operative procedures and prepared for
pathological diagnosis. Tissue procurement was approved by
the ethics board in Nagoya University Graduate School of
Medicine. All cases of CC had histologically determined ade-
nocarcinoma of variable differentiation. Cancerous large bile
ducts (CC cells replacing the luminal surface of the original
intrahepatic large bile ducts), which were available in five
cases, had a micropapillary pattern of adenocarcinoma in
their lumen, while at the invasive front areas or border, the
CC, which were available in all cases, had a tubular or cord-
like pattern of adenocarcinoma with significant desmoplastic
reaction. All tissue specimens were fixed in neutral formalin,
and embedded in paraffin. More than 20 serial sections, 3 µm
thick, were cut from each paraffin block, and were used for
routine histological stainings including HE and also for the
immunohistochemistry.
Antibodies and immunological reagents
We used a goat polyclonal antibody against SDF-1 (Santa
Cruz Biotechnology, Santa Cruz, CA, USA), and a mouse
monoclonal antibody against TGF-β1 (clone TB21; Chemi-
con, Temecula, CA, USA) for immunohistochemistry. Prein-
cubation of anti-SDF-1 with SDF-1 resulted in a marked
reduction. The specificity of anti-TGF-β1 was confirmed by
western blotting. We also used recombinant human TGF-β1
(R&D systems, Minneapolis, MN, USA).
Immunohistochemical staining of SDF-1 and TGF-b1
Expression of SDF-1 and TGF-β1 in CC cells and stromal
cells within CC tissue was immunohistochemically examined
by using the Envision+ system (Dako, Santa Barbara, CA,
USA). Briefly, deparaffinized sections were pretreated in a
microwave oven in EDTA buffer at 95°C, 20 min for SDF-1.
After blocking endogenous peroxidase in 1% H2O2 in meth-
anol for 20 min at room temperature and then non-specific
reaction in Proteinblock Serum (Dako) for 15 min at room
temperature, deparaffinized sections were incubated with
each primary antibody at 1:50 dilution for SDF-1, and 1:1000
dilution for TGF-β1 at 4°C overnight. The Envision+ solution
for mouse or goat (Dako) was then applied for 60 min at room
temperature. The reaction products were visualized by 3,3′-
diaminobenzidine tetrahydrochloride (Sigma Chemical, St
Louis, MO, USA), and the sections were then lightly counter-
stained with hematoxylin. Negative controls included substi-
tuting the primary antibody with similarly diluted mouse or
goat control immunoglobulin G (Dako).
Expression of SDF-1 and TGF-β1 was mainly examined in
two areas of CC: at the border or invasive front areas of CC
and around the carcinomatous large bile ducts in which pap-
illary-shaped or stratified carcinoma remained or was identi-
fiable on the luminal surface. The former area was available
in all 12 cases, while the latter was available in five of 12
cases.
Cell culture
Two cell lines of CC (HuCCT-1, Cell Resource Center for
Biochemical Research, Tohoku University; and CCKS-1,
established in our laboratory at Kanazawa University Gradu-
ate School of Medicine23,24) and one cell line of fibroblasts
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(WI-38, embryonic lung fibroblasts, Cell Resource Center for
Biochemical Research, Tohoku University) were used. These
cells were maintained in RPMI-1640 medium containing 10%
fetal calf serum (FCS) and penicillin–streptomycin–glutamine
(Gibco-BRL, Grand Island, NY, USA).
Invasion assays of cultured CC cells
Migration of CC cells was assayed using Matrigel Invasion
Chambers (24-well format, 8 µm pore; BD Bioscience, Bed-
ford, MA, USA). Medium (0.5 µL) containing 5 × 105 CC cells
(HuCTT-1 and CCKS-1) was added to the upper chamber,
and 0.5 mL of either supernatant with WI-38 alone or WI-38
cultured with CC cells, was added to the lower chamber.
Chambers were incubated for 48 h at 37°C and 5% CO2. The
CC cells in the upper surface of the filter were then removed
using a cotton wool swab. Migrated cells on the lower surface
were stained using 1% toluidine blue after fixing with 100%
methanol. The number of migrated cells in 10 medium-power
fields (×20) was counted, and the experiments were con-
ducted in triplicate. The data were compared and evaluated
by calculating the invasion index (no. migrating cells in an
experimental group/no. migrating cells in control groups with-
out coculture, in culture fluid, or in other reagent).
RNA extraction and reverse transcription–polymerase 
chain reaction
RNA was isolated from cultured WI-38 fibroblasts using the
Qiagen RNAeasy kit (Qiagen, Santa Clarita, CA, USA). RNA
was then used for first-strand cDNA synthesis with the
superscript  reamplification  system  (Gibco-BRL),  according
to the manufacturer’s instructions. Reverse transcription–
polymerase  chain  reaction  (RT-PCR)  for  TGF-β  receptor
type I (TβRI), TGF-β receptor type II (TβRII) and β-actin were
then performed. The following primers were designed
complementary  to  the  published  nucleotide  sequence:
β-actin (forward, 5′-CAA-GAG-ATG-GCC-ACG-GCT-GCT-3′;
reverse, 5′-TCC-TTC-TGC-ATC-CTG-TCG-GCA-3′; PCR pro-
duct size, 275 bp); TβRI (forward, 5′-AAC-CGC-ACT-GTC-
ATT-CAC-3′; reverse, 5′-TTC-CTC-TCC-AAA-CTT-CTC-C-3′;
PCR product size, 220 bp); TβRII forward, 5′-ATG-GAG-TTC-
AGC-GAG- CAC-3′; reverse, 5′-CAC-AGG-CAG-CAG-GTT-
AGG-3′; PCR product size, 560 bp).21,22
The PCR conditions consisted of a denaturing step at 94°C
for 30 s, an annealing step at 60°C (β-actin), 58°C (TβRI), or
61°C (TβRII) for 1 min, and an extension step at 72°C for
1 min for one cycle, followed by 18 cycles (β-actin) or 29
cycles (TβRI and TβRII). After PCR, 5 µL aliquots of the
products were subjected to 1.5% or 2.0% agarose gel elec-
trophoresis and stained with ethidium bromide.
Protein extraction and western blot analysis for TGF-b1
Proteins were extracted from cultured CC cells (HuCCT-1
and CCKS-1) using T-PER Tissue Protein Extraction Reagent
(Pierce Chemical, Rockford, IL, USA). Total protein was mea-
sured by a spectrophotometer. A total of 20 µg of extracted
protein was used for western blot analysis.
The analysis was performed on 10% sodium dodecylsul-
fate–polyacrylamide gel electrophoresis for TGF-β1. The pro-
teins in the gel were electrophoretically transferred onto
nitrocellulose membrane. The membranes were incubated
with primary antibodies to TGF-β1. These proteins were
detected using second antibodies conjugated to peroxidase-
labeled polymer  Envision+  solution  (Dako)  for  mouse.  3-
3′-Diaminobenzidine tetrahydrochloride was used as the
chromogen.
Real-time PCR for SDF-1 mRNA in WI-38 fibroblasts
WI-38 fibroblasts were cultured alone or were cocultured with
CC cells (HuCCT-1 or CCKS-1) in Transwell 4 µm-pore tissue
culture dish (Corning, Corning, NY, USA) for 48 h. RNA was
isolated from these cultured WI-38 fibroblasts, and multiplex
real-time  analysis  was  performed  using  premade  SDF-1
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-
specific primers and probes with the ABI Prism 7700
Sequence Detection System instrument and software (PE
Applied Biosystems, Warrington, UK). RT-PCR was carried
out with the TaqMan Universal RT-PCR Master Mix (PE
Applied Biosystems) using 5 µL cDNA in a 25 µL final reac-
tion mixture. Cycling conditions were incubation at 50°C for
2 min, 10 min at 95°C, and 40 cycles of 15 s at 95°C and
1 min at 60°C. Experiments were performed in duplicate for
each sample, and SDF-1 was normalized (∆Ct) to GAPDH
by subtracting the cycle threshold (Ct) value of GAPDH from
the Ct value of SDF-1. Fold difference compared with control
was calculated. Our preliminary study showed that CC cells
of the two cell lines failed to express SDF-1 mRNA.
Measurement of SDF-1 production
First, the baseline SDF-1 production from cultured WI-38
fibroblasts and CC cells (HuCCT-1 and CCKS-1) was deter-
mined. Either of these three cell lines was seeded on 6 cm
culture dishes at a density of 1 × 105/mL and cultured for
24 h. After replacing the media with fresh RPMI1640, the
cells were cultured for another 48 h. Concentration of SDF-
1 in the supernatant was measured by enzyme-linked immu-
nosorbent assay (ELISA) using a human SDF-1 and Enzyme
Immunoassay kit (R&D systems), according to the manufac-
turer’s instructions.
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For the analysis of influence of cultured CC cells on SDF-
1 expression by WI-38 fibroblasts, the coculture of CC cells
with WI-38 fibroblasts in the following combination was done.
That is, at the density of WI-38 fibroblasts to CC cells of 1:10
and 1:100 both CC and WI-38 cells were cocultured for 48 h.
As controls, WI-38 fibroblasts alone or either of the two CC
cell lines alone were cultured. Then, the conditioned culture
media were harvested from each coculture system, and
SDF-1 protein was evaluated by ELISA. Preliminary studies
showed that CC cells of the two cell lines did not express
SDF-1 protein.
Statistical analysis
The difference among two or three groups was assessed by
Mann–Whitney U-test. Significance was taken for P < 0.05.
RESULTS
Expression of SDF-1 and TGF-b1 in human CC tissues
TGF-β1 was strongly expressed in the cytoplasm of endot-
helial cells and also in fibroblast-like stromal cells within CC.
It was also positive diffusely in the cytoplasm of a variable
number of CC cells of all CC cases; expression of TGF-β1
in CC cells was variable according to the location in CC. That
is, TGF-β1 was frequently and strongly expressed in carci-
noma growing within the lumen of cancerous large bile ducts
in five cases examined (Fig. 1a), while at invasive areas of
CC, the expression of TGF-β1 in CC cells was negative or
minimal in nine cases and focally positive in the remaining
three cases (Fig. 1b).
SDF-1 was expressed in the cytoplasm of fibroblast-like
stromal cells and also endothelial cells within CC, although
the distribution of positive cells and their staining intensity
were variable in individual cases. Around the cancerous large
bile ducts, expression of SDF-1 in fibroblasts was minimal or
absent. At the border of CC reflecting invasive fronts, SDF-
1-positive fibroblast-like stromal cells were usually observed
Figure 1 Expression of tumor growth factor (TGF)-β1. (a) Expression of TGF-β1 is evident in carcinoma cells of cancerous large bile duct
(the lumen of original intrahepatic large bile duct is replaced by micropapillary carcinoma). Several stromal cells, particularly endothelial cells,
are also positive for TGF-β1. (b) TGF-β1 expression in carcinoma cell (*) is vague or negative at the invasive front of cholangiocarcinoma
(CC). Several stromal cells, particularly endothelial cells, are strongly positive for TGF-β1. (a) immunohistochemistry for TGF-β1 and
hematoxylin; (b) immunohistochemistry for TGF-β1 and hematoxylin.
a b
Figure 2 Expression of stromal-derived factor (SDF)-1. SDF-1
expression is evident in several fibroblast-like stromal cells and
endothelial cells (arrows) at the invasive front of cholangiocarci-
noma. Carcinoma cells (*) are negative for SDF-1. Immunohis-
tochemistry for SDF-1 and hematoxylin.
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(Fig. 2). Expression of SDF-1 was evident in fibroblasts at
the invasive front zones in nine cases. In the remaining three
cases, SDF-1 expression in fibroblasts was minimal or
absent.
Influence of cultured WI-38 fibroblasts on invasion of 
cultured CC cells
Next, we examined the influence of cultured WI-38 fibroblasts
on the migration of CC cells (HuCTT-1 and CCKS-1), by
using migration assay. Migration assay of cultured CC cells
was measured by addition of the supernatant without cellular
elements, which was obtained from the culture dishes in
which (i) only WI-38 fibroblasts were cultured, and from those
in which WI-38 fibroblasts were cocultured with either of (ii)
HuCCT-1 or (iii) CCKS-1 cells, for 48 h. As shown in Fig. 3,
invasion of cultured CC cells was significantly increased by
addition of the supernatant from (i) (2.6 ± 0.8-fold in HuCCT-
1 and 7.6 ± 3.8-fold in CCKS-1), while this increased invasion
was significantly reduced to 2.0 ± 0.8-fold in HuCCT-1 cells
and to 4.0 ± 2.2-fold in CCKS-1, respectively, when the
supernatant obtained from (ii) or (iii) were added (each,
P < 0.05). These data suggest that cultured WI-38 fibroblasts
secreted molecule(s) that increased invasion of cultured CC
cells and that coculture of WI-38 fibroblasts with CC cells
secreted molecule(s) that partially inhibited the increased
invasion of CC cells induced by WI-38.
Influence of cultured CC cells on the expression of 
SDF-1 mRNA and protein in WI-38 fibroblasts
Real-time PCR and ELISA showed that SDF-1 mRNA was
detectable in cultured WI-38 fibroblasts, and that cultured
WI-38 fibroblasts secreted 172 ± 22.2 pg/mL SDF-1 in the
culture fluid (Fig. 4a,b). When WI-38 fibroblasts were cul-
tured in a cell ratio of 1:1.5, SDF-1 in the culture fluid
increased to 1.3-fold (221 ± 10.1 pg/mL). These data indi-
cate that the increased cell density up to 1.5-fold does not
suppress the secretion of SDF-1. Interestingly, the level of
SDF-1 mRNA in WI-38 fibroblasts was significantly
decreased when they were cocultured with CC cells of either
of the two cell lines (to 0.28 ± 0.01-fold, HuCCT-1; to
0.15 ± 0.08 fold, CCKS-1; P < 0.05, respectively). Next, WI-
38 fibroblasts were cocultured with a variable number of CC
cells (Fig. 4c): when the number of cocultured CC cells was
increased stepwise, secretion of SDF-1 protein was
decreased stepwise (from 98 ± 22.2 pg/mL to 66 ± 22.2 pg/
mL in HuCCT-1 and from 169 ± 40.4 pg/mL to 80 ± 38.5 pg/
mL in CCKS-1). These results indicate that cultured CC cells
influenced the expression of mRNA and the secretion of
SDF-1 protein in WI-38 fibroblasts, probably by secretion of
soluble molecule(s).
TGF-b1 secreted by CC cells downregulates expression 
of SDF-1 in WI-38 fibroblasts
Carcinoma cells of several organs are well-known to express
and secrete TGF-β1, and it was found by immunohistochem-
istry in the present study that TGF-β1 was expressed in CC
cells (Fig. 2). Western blotting showed that TGF-β1 was pro-
duced by cultured HuCCT-1 cells and also by CCKS-1 cells
(Fig. 5). Therefore, we tested the possibility that TGF-β1
secreted from cultured CC cells reduced SDF-1 mRNA
expression and protein secretion by cultured WI-38 fibro-
blasts. SDF-1 protein secreted by WI-38 fibroblasts
(172 ± 22.2 pg/mL) was reduced to 70 ± 37 pg/mL by treat-
ment with 10 ng/mL TGF-b1 (P < 0.05; Fig. 6a). The expres-
Figure 3 Invasion assay of cholangio-
carcinoma (CC) cells in Matrigel inva-
sion chamber. Invasion of cultured CC
cells from either (a) HuCCT-1 or (b)
CCKS-1 is increased when the cells are
incubated with the supernatant from cul-
ture dishes in which WI-38 fibroblasts
alones are cultured for 48 h. The inva-
sion of HuCCT-1 cells is increased by
2.6 ± 0.8-fold, and that of CCKS-1 by
7.6 ± 3.8-fold, compared with the control
(only CC cells cultured; *P < 0.05).
When CC cell lines are cultured with
addition of the cultured fluid from WI-38
fibroblasts cocultured with HuCCT-1 CC
cells or CCKS-1 CC cells, the increase
in invasion of CC cells is limited to
2.2 ± 0.8-fold and 4.0 ± 2.2 fold, respec-
tively (**P < 0.05 vs WI-38 fibroblasts
alone).
(a) (b)
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sion of SDF-1 mRNA in WI-38 fibroblasts was also reduced
significantly to 0.30 ± 0.18-fold by 10 ng/mL TGF-β1 treat-
ment, compared to control (without TGF-β1 treatment;
P < 0.05; Fig. 6b). These data strongly suggest that SDF-1
mRNA expression and protein secretion in cultured WI-38
fibroblasts was downregulated by TGF-β1. As for receptors
for TGF-β1, RT-PCR showed that WI-38 fibroblasts
expressed both TβRI and TβRII mRNA (Fig. 7), suggesting
that WI-38 fibroblasts reacted with TGF-β1 via these
receptors.
Interestingly, reduced expression of SDF-1 mRNA in WI-
38 fibroblasts cocultured with CC cell lines (0.28 ± 0.01-fold
in HuCCT-1 cells and 0.14 ± 0.08-fold in CCKS-1 cells,
respectively) was partially recovered when 5 µg/mL anti-
TGF-β1 neutralization antibody was added to the culture
medium (0.33 ± 0.10-fold in HuCCT-1 cells and 0.47 ± 0.03-
fold in CCKS-1 cells, respectively; Fig. 8). These data sup-
port the aforementioned suggestion. However, this recovery
was statistically significant in CCKS-1 cells but not in HuCCT-
1 cells. Because the recovery was not complete even in
CCKS-1, it is suggested that other factors may be acting with
TGF-β1 for the suppression of SDF-1 expression. Such fac-
tors might be responsible for the lower effect of TGF-β1
antibody neutralization in HuCCT-1 cells.
Figure 4 Effects of coculture of cholangiocarcinoma (CC) cell lines on the expression of stromal-derived factor-1 (SDF-1) in WI-38 fibroblasts.
(a) Real-time polymerase chain reaction shows that SDF-1 mRNA expression in WI-38 fibroblasts is decreased to 0.28 ± 0.01-fold in the
coculture with HuCCT-1 and to 0.15 ± 0.08-fold in the coculture with CCKS-1, compared with control (WI-38 fibroblasts cultured alone). (b)
WI-38 fibroblasts cultured alone secrete 172 ± 22.2 pg/mL of SDF-1. Secretion of SDF-1 protein is decreased to 98 ± 22.2 pg/mL and further
to 66 ± 22.2 pg/mL when WI-38 cells are cocultured with increasing amounts of HuCCT-1 cells, and secretion of SDF-1 protein is decreased
to 169 ± 40.4 pg/mL and further to 80 ± 38.5 pg/mL when WI-38 cells are cocultured with increasing amounts of CCKS-1 cells. HuCCT-1 cells
or CCKS-1 cells alone do not secrete SDF-1 protein. *P < 0.05 to WI-38 cells; **P < 0.05 to WI-38 cells + CCKS-1/100. (c–e) Phase-contrast
photographs of representative examples of the cocultured HuCCT1 cells and WI-38 fibroblasts. (c) Only 1 × 105 cells/mL WI-38 fibroblasts
are seeded and cultured. (d) 1 × 105 cells/mL WI-38 fibroblasts and 1 × 103 cells/mL HuCCT-1 cells (WI-38 cells : HuCCT-1 cells, 100:1) are
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Taken together, it seems likely that TGF-β1 secreted from
cultured CC cells downregulated SDF-1 mRNA and protein
expression in WI-38 fibroblasts.
DISCUSSION
Recently, several molecules such as HGF, SDF-1, and EGF
have been reported as effective molecules involved in the
cross-talk in the tumor–stromal interactions in malignant
tumors.6,9–11 Among them, the SDF-1–CXCR4 axis is impor-
tant in the progression of malignant tumors. SDF-1 is
known to be produced in stromal fibroblasts and CXCR4 is
reportedly expressed on tumor cells in some malignant
neoplasms.11,25–29 Our previous study showed that the inva-
sion of cultured CC cells in Matrigel was increased by
SDF-1 secreted from cultured WI-38 fibroblasts, and SDF-
1–CXCR4 interaction was involved in this increased
invasion.12
In the present study we further examined the interaction
between stromal fibroblasts and CC cells with respect to
TGF-β1 and SDF-1, using culture studies of CC cell lines and
immunohistochemistry for human CC tissues. First, it was
found that the invasion of cultured CC cells (HuCCT-1 and
CCKS-1) was increased significantly when these CC cells
were treated with the supernatant from the culture of WI-38
fibroblasts for 48 h, confirming our previous study.12 Interest-
ingly, when these CC cells were treated with the supernatant
obtained from the coculture of WI-38 fibroblasts and CC cells,
the increased invasion of CC cells was significantly reduced,
suggesting that the cultured CC cells might have secreted a
soluble factor that inhibited the increased invasion of CC cells
induced by the supernatant from cultured WI-38 fibroblasts.
It is noteworthy that SDF-1 mRNA and protein expression in
WI-38 fibroblasts were decreased when they were cocultured
with either of two CC cell lines, and this is compatible with
the aforementioned data that SDF-1 secreted from WI-38
fibroblasts mediates the increased invasion of CC cells.12
Wright et al. reported that in the bone marrow, TGF-β1
downregulates the expression of SDF-1 in bone marrow stro-
mal cells.19 It was found in the present study that TGF-β1 was
expressed in cultured CC cells (HuCCT-1 and CCKS-1) by
western blotting. Therefore, we tested the possibility that
Figure 5 Detection of tumor growth factor (TGF)-β1 in cultured
cholangiocarcinoma (CC) cells (HuCCT-1 and CCKS-1) by western
blotting. TGF-β1 (12.5 kDa) was detected in both CC cell lines
(HuCCT-1 and CCKS-1; arrow). In HuCCT-1, a dimeric form of TGF-
β1 (25 kDa) was also detected (arrowhead). A protein (15–17 kDa)
was also detected (*) in HuCCT-1, but the details of this protein
remain unclear. This might be a precursor of TGF-β1 truncated
irregularly.
Figure 6 Influence of transforming
growth factor (TGF)-β1 on expression of
stromal-derived factor (SDF)-1 mRNA
and protein in cultured WI-38 fibroblasts.
(a) ELISA showed that SDF-1 protein
secreted by WI-38 cells is 172 ± 22.2 pg/
mL without TGF-β1 treatment and this is
reduced to 70 ± 37 pg/mL on treatment
with 10 ng/mL TGF-β1 (*P < 0.05). (b).
Real-time quantitative polymerase chain
reaction shows that SDF-1 mRNA
expression in WI-38 fibroblasts without
treatment is reduced to 0.30 ± 0.18-fold
by treatment with 10 ng/mL TGF-β1
(*P < 0.05).
(a) (b)
Figure 7 Expression of mRNA for two transforming growth factor
(TGF)-β1 receptor, TGF-β receptor type I (TβRI) and TGF-β receptor
type II (TβRII) mRNA in WI-38 fibroblasts detected by reverse tran-
scription–polymerase chain reaction.
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TGF-β1 secreted by CC cells downregulated the expression
of SDF-1 in WI-38 fibroblasts, and then inhibited the invasion
of CC cells. Interestingly, when TGF-β1 was added to the
medium of WI-38 fibroblasts culture, the production of SDF-
1 by WI-38 fibroblasts was decreased. RT-PCR showed that
WI-38 fibroblasts expressed both TGF-β type I and II recep-
tors, suggesting that TGF-β1 secreted from CC cells might
have downregulated the expression of SDF-1mRNA in WI-38
fibroblasts  via  these  receptors.  In  fact,  administration  of
anti-TGF-β1 neutralization antibody tended to restore the
decreased SDF-1 expression in cultured WI-38 fibroblasts by
coculture with either of the CC cells, and this restoration was
statistically significant in CCKS-1, suggesting that the down-
regulation of SDF-1 expression in WI-38 fibroblasts cocul-
tured with CC cells might have been mediated via TGF-β1.
Taken together, our results show that TGF-β1 secreted from
cultured CC cells downregulated SDF-1 expression in fibro-
blasts, and that reduced expression of TGF-β1 in carcinoma
cells downregulated the invasion-promoting SDF-1–CXCR4
axis of CC at invasive fronts of CC.
We also immunohistochemically examined the correlation
between expression of SDF-1 in stromal cells and TGF-β1 in
carcinoma cells within human CC tissue specimens. We
found that TGF-β1 was expressed in CC cells of all CC cases,
although the expression was quite variable. CC cells
expressing TGF-β1 were focal or scarce at the invasive fronts
of  CC,  while  the  expression  of  TGF-β1  was diffuse and
strong around CC growing in the lumen of cancerous large
bile ducts. We also found that although SDF-1 was expressed
heterogeneously in several fibroblast-like stromal cells and
endothelial cells in CC, its expression was pronounced at
invasive areas or fronts of CC. These findings suggest that
decreased expression of TGF-β1 in CC cells is likely to medi-
ate the increased expression of SDF-1 in stromal fibroblasts
at the invasive fronts, where carcinoma cells are likely to
invade or migrate actively into the surrounding tissue.21,22 In
preliminary data, the clinical stage of three patients with CC
in whom the expression of TGF-β1 was positive in CC cells
at the invasive front appeared to be low when compared with
the remaining nine patients in whom the expression of TGF-
β1 was absent at the invasive front. However, the number of
patients was limited and there was no difference statistically
between the two groups. Further study using a large number
of patients is needed to confirm this point.
There were TGF-β1-positive cells such as endothelial cells,
other than CC cells, in CC tissue, suggesting that the tumor–
stroma interactions via TGF-β1 and SDF-1 expressed in cells
and processes other than those discussed in the present
study, may also contribute to the progression of CC.
In conclusion, the data obtained here suggest that SDF-1
secreted from cultured WI-38 fibroblasts increased invasion
of CC cells and that TGF-β1 secreted from CC cells inhibited
expression of SDF-1 by stromal fibroblasts, and then reduced
the increased migration of CC cells induced by SDF-1. This
suggests that the reduced secretion of TGF-β1 from CC cells
may induce increased expression of SDF-1 in stromal fibro-
blasts and then lead to increased invasion of CC cells. Immu-
nohistochemical findings suggesting expression of SDF-1 in
stromal fibroblasts and lowered or absent expression of TGF-
β1 on CC cells at the invasive fronts of CC may represent
the action of a local factor favorable to the invasion of CC
cells. Therefore, augmentation therapy of TGF-β1 expression
in CC cells could downregulate the expression of SDF-1 in
stromal fibroblasts and inhibit the invasion of CC.
Figure 8 Effects of transforming
growth factor (TGF)-β1 neutralization
antibody. When TGF-β1 neutralization
antibody is added to the medium of WI-
38 fibroblasts cocultured with cholangio-
carcinoma (CC) cell lines in Transwell
4 µm-pore tissue culture dish, stromal-
derived factor (SDF)-1 mRNA expres-
sion is partially restored in (a) HuCCT-1
cells to 0.33 ± 0.10-fold and (b) CCKS-1
cells to 0.47 ± 0.0.03-fold, when com-
pared to that without addition of this anti-
body (HuCCT-1 cells, 0.28 ± 0.01-folds;
CCKS-1 cells, 0.14 ± 0.08-fold). This
restoration is statistically significant for
CCKS-1 (*P < 0.05). These data suggest
that TGF-β1 produced in CC cells con-
tributes to downregulation of SDF-1
mRNA expression in WI-38 fibroblasts.
(a) (b)
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